Holden Comprehensive Cancer Center Clinical Research Opportunities
Holden Comprehensive Cancer Center is working to discover more about the origins, prevention, development and treatment of cancer. We are focused on translating research advances in the laboratory to advances in patient care. Clinical trials are an important step in that process. At any given time, Holden offers more than 300 active clinical trials. Each trial is carefully monitored and regulated to safeguard patient safety and privacy, and to ensure data integrity.
For information about how the Holden Comprehensive Cancer Center monitors and regulates clinical trials, click on the links below:
- Oncore: Searchable Clinical Trials Database
- Clinical Research Services
- Protocol Development and Monitoring
- Protocol Review and Monitoring Committee (PRMC)
- PRMC Accrual Monitoring and Closure Policy
- PRMC Submission Guidelines
- Data and Safety Monitoring Committee (DSMC)
Additional Cancer Clinical Research Resources
These online resources can assist you in finding and learning more about cancer-related clinical research.
- State of Iowa Clinical Research
- National Cancer Institute
- CenterWatch Blood and Marrow Cancers Clinical Research
- CenterWatch Solid Tumor Clinical Research
The intent of clinical research is to look for new and better ways to prevent, detect, diagnose, or treat a disease.
Nearly one in ten patients cared for at Holden Comprehensive Cancer Center are part of a clinical trial that includes treatment for their disease. And, nearly one quarter of our cancer patients participate in clinical research that may go beyond the scope of treatment and include research done on blood samples, tissue samples, and diagnostic imaging.
Members of Holden Comprehensive Cancer Center conduct clinical research studies to test the safety or effectiveness of experimental medications or devices in patients. As an institution, we believe that bench research makes a difference in bedside medicine.
People participating in clinical research have access to experimental medications or devices before they become available to the general public. If you participate, you may receive careful medical attention including examinations and tests at no cost. In some cases, you may be reimbursed for your time and expenses, such as travel.
If you need assistance, the Cancer Information Service staff at the Holden Comprehensive Cancer Center will run a search for you. Their nationwide toll-free number is 1-800-237-1225.